Higher metabolic risk with national institutes of health versus rotterdam diagnostic criteria for polycystic ovarian syndrome in Turkish women

Metabolic Syndrome and Related Disorders

Volumn 9, Issue 5, 2011, Pages 375-380

  Anaforoglu, Inan ^a   Algun, Ekrem ^a   Incecayir, Omer ^a   Ersoy, Kerem ^a  

^a Trabzon Numune Education and Research Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

GONADOTROPIN; HYDROXYPROGESTERONE; INSULIN; LIPID; PRASTERONE; TESTOSTERONE; TRIACYLGLYCEROL;

ADULT; ANDROGEN BLOOD LEVEL; ARTICLE; BODY MASS; CASE CONTROL STUDY; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; GESTAGEN BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GONADOTROPIN BLOOD LEVEL; HIRSUTISM; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; NATIONAL HEALTH ORGANIZATION; ORAL GLUCOSE TOLERANCE TEST; OVARY INSUFFICIENCY; OVARY POLYCYSTIC DISEASE; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK; TESTOSTERONE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; TURKEY (REPUBLIC); WAIST CIRCUMFERENCE;

ADULT; BODY MASS INDEX; CASE-CONTROL STUDIES; FEMALE; GLUCOSE TOLERANCE TEST; HIRSUTISM; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; METABOLIC SYNDROME X; PHENOTYPE; POLYCYSTIC OVARY SYNDROME; PROSPECTIVE STUDIES; RISK; TURKEY;

EID: 80053473268     PISSN: 15404196     EISSN: 15578518     Source Type: Journal    
DOI: 10.1089/met.2011.0019     Document Type: Article

References (43)

1. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: A prospective study. J Clin Endocrinol Metab 1998;83:3078-3082. (Pubitemid 28500937)
2. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004;89:2745-2749. (Pubitemid 38766360)
3. Apridonidze T, Essah PA, Iuorno MJ, Nestler JE. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005;90:1929-1935. (Pubitemid 40586223)
4. Legro RS, Kunselman AR, Dodson WC, Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: A prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 1999;84:165-169. (Pubitemid 29036695)
5. Meyer C, McGrath BP, Cameron J, Kotsopoulos D, Teede HJ. Vascular dysfunction and metabolic parameters in polycystic ovary syndrome. J Clin Endocrinol Metab 2005;90:4630-4635. (Pubitemid 41159353)
6. Meyer C, McGrath BP, Teede HJ. Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease. J Clin EndocrinolMetab 2005;90:5711-5716. (Pubitemid 41415480)
7. Shaw LJ, Bairey Merz CN, Azziz R, Stanczyk FZ, Sopko G, Braunstein GD, Kelsey SF, Kip KE, Cooper-Dehoff RM, Johnson BD, Vaccarino V, Reis SE, Bittner V, Hodgson TK, Rogers W, Pepine CJ. Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: Results from the National Institutes of Health-National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation. J Clin Endocrinol Metab 2008;93:1276-1284. (Pubitemid 351519721)
8. Himelein MJ, Thatcher SS. Polycystic ovary syndrome and mental health: A review. Obstet Gynecol Surv 2006;61:723-732. (Pubitemid 44655530)
9. Stein I, Leventhal M. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 1935;29:181.
10. Zawadski JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine F, eds. Polycystic ovary syndrome. Boston: Blackwell Scientific, 1992:377-384.
11. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary synrome (PCOS). Hum Reprod 2004;19:41-47.
12. Azziz R. Diagnostic criteria for polycystic ovary syndrome: A reappraisal. Fertil Steril 2005;83:1343-1346. (Pubitemid 40615803)
13. Geisthö vel F. A comment on the European Society of Human Reproduction and Embryology/American Society for Reproductive Medicine consensus of the polycystic ovarian syndrome. Reprod Biomed Online 2003;7:602-605. (Pubitemid 37527167)
14. Jonard S, Robert Y, Dewailly D. Revisiting the ovarian volume as a diagnostic criterion for polycystic ovaries. Hum Reprod 2005;20:2893-2898. (Pubitemid 41487648)
15. Lam PM, Ma RCW, Cheung LP, Chow CC, Chan JCN, Haines CJ. Polycystic ovarian syndrome in Hong Kong Chinese women: Patient characteristics and diagnostic criteria. Hong Kong Med J 2005;11:336-341. (Pubitemid 41499551)
16. Amato MC, Galluzzo A, Merlino S, Mattina A, Richiusa P, Criscimanna A, Giordano C. Lower insulin sensitivity differentiates hirsute from non-hirsute Sicilian women with polycystic ovary syndrome. Eur J Endocrinol 2006;155:859-865. (Pubitemid 46040625)
17. Broekmans FJ, Knauff EA, Valkenburg O, Laven JS, Eijkemans MJ, Fauser BC. PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors. BJOG 2006;113:1210-1217. (Pubitemid 44401217)
18. Pehlivanov B, Orbetzova M. Characteristics of different phenotypes of polycystic ovary syndrome in a Bulgarian population. Gynecol Endocrinol 2007;23:604-609. (Pubitemid 47613725)
19. Hsu MI, Liou TH, Chou SY, Hsu CS. Diagnostic criteria for polycystic ovary syndrome in Taiwanese Chinese women: comparison between Rotterdam 2003 and NIH 1990. Fertil Steril 2007;88:727-729.
20. Chae SJ, Kim JJ, Choi YM, Hwang KR, Jee BC, Ku SY, Suh CS, Kim SH, Kim JG, Moon SY. Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women. Hum Reprod 2008;23:1924-1931. (Pubitemid 352020025)
21. Lam PM, Tam WH, Cheung LP. Higher metabolic risk in Chinese women fulfilling the NIH diagnostic criteria for polycystic ovarian syndrome. Fertil Steril 2009;91:1493-1494.
22. Moran L, Teede H. Metabolic features of the reproductive phenotypes of polycystic ovary syndrome. Hum Reprod 2009;15:477-488.
23. Guastella E, Longo RA, Carmina E. Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes. Fertil Steril 2010;94:2197-2201.
24. Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961;21:1440-1447.
25. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28: 412-419. (Pubitemid 15018832)
26. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
27. BalenAH, Conway GS, Kaltsas G, Techatrasak K,Manning PJ, West C, Jacobs HS. Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum Reprod 1995;10:2107-2111.
28. Achard EC, Thiers J. Le virilisme pilaire et son association à l'insuffisance glycotique (diabète des femmes à barbe). Bull Acad Natl Med (Paris) 1921;86:51-56.
29. Burghen GA, Givens JR, Kitabchi AE. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab 1980;50:113-116. (Pubitemid 10203585)
30. Diamanti-Kandarakis E, Papavassiliou AG. Molecular mechanisms of insulin resistance in polycystic ovary syndrome. Trends Mol Med 2006;12:324-332. (Pubitemid 44094292)
31. Wu XK, Zhou SY, Liu JX, Pö llänen P, Sallinen K, Mäkinen M, Erkkola R. Selective ovary resistance to insulin signaling in women with polycystic ovary syndrome. Fertil Steril 2003;80:954-965. (Pubitemid 37230033)
32. Rice S, Christoforidis N, Gadd C, Nikolaou D, Seyani L, Donaldson A, Margara R, Hardy K, Franks S. Impaired insulin-dependent glucose metabolism in granulosa-lutein cells from anovulatory women with polycystic ovaries. Hum Reprod 2005;20:373-381. (Pubitemid 40277604)
33. Azziz R, Carmina E, Sawaya ME. Idiopathic hirsutism. Endocr Rev 2000;21:347-362. (Pubitemid 32279644)
34. Unluhizarci K, Gokce C, Atmaca H, Bayram F, Kelestimur F. A detailed investigation of hirsutism in a Turkish population: Idiopathic hyperandrogenemia as a perplexing issue. Exp Clin Endocrinol Diabetes 2004;112:504-509. (Pubitemid 39457627)
35. Sarac F, Saygili F, Ozgen G, Tuzun M, Yilmaz C. Assessment of insulin resistance in the idiopathic hirsutism. Gynecol Obstet Invest 2007;63:126-131. (Pubitemid 46514797)
36. Abdel Fattah NS, Darwish YW. Is there a role for insulin resistance in nonobese patients with idiopathic hirsutism? Br J Dermatol 2009;160:1011-1015.
37. Kuo J, Kumar A, Decherney AH, Azziz R. Are patients with idiopathic hirsutism (IH) insulin resistant? Comparing women with IH to body mass index-matched patients with polycystic ovary syndrome and controls. Fertil Steril 2004;82(Suppl 2):301-302.
38. Frajndlich R, Spritzer PM. Association between ovarian volume and serum insulin levels in ovulatory patients with idiopathic hirsutism. Fertil Steril 2005;83:1561-1564. (Pubitemid 40615843)
39. Williamson K, Gunn AJ, Johnson N, Milsom SR. The impact of ethnicity on the presentation of polycystic ovarian syndrome. Aust NZ J Obstet Gynaecol 2001;41:202-206. (Pubitemid 32515023)
40. Sagsoz N, Kamaci M, Orbak Z. Body hair scores and total hair diameters in healthy women in the Kirikkale region of Turkey. Yonsei Med J 2004;45:483-491. (Pubitemid 39010707)
41. Yildiz BO, Bolour S, Woods K, Moore A, Azziz R. Visually scoring hirsutism. Hum Reprod Update 2010;16:51-64.
42. Martin KA, Chang RJ, Ehrmann DA, Ibanez L, Lobo RA, Rosenfield RL, Shapiro J, Montori VM, Swiglo BA. Evaluation and treatment of hirsutism in premenopausal women: An Endocrine Society clinical practice guideline. J Clin Endocrinol Met 2008;93:1105-1120. (Pubitemid 351519694)
43. Azziz R. Controversy in clinical endocrinology: Diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature. J Clin Endocrinol Met 2006;91:781-785. (Pubitemid 43357736)